MAPT and Alzheimer disease: This type of APOE ɛ4−sex interaction has been shown in a biomarker that distinguishes Alzheimer’s disease (tau pathology), and stronger relationships between APOE ɛ4 allele and greater values in biomarkers of Alzheimer’s disease are observed in females (Altmann et al.